about
Night-time heart rate cut-off point definition by resting office tachycardia in untreated hypertensive patients: data of the Spanish ABPM registry.Burden of multimorbidity, socioeconomic status and use of health services across stages of life in urban areas: a cross-sectional studyCharacterization of new users of cilostazol in the UK, Spain, Sweden, and GermanyImpact of multimorbidity: acute morbidity, area of residency and use of health services across the life span in a region of south Europe.Multimorbidity Patterns in Elderly Primary Health Care Patients in a South Mediterranean European Region: A Cluster Analysis.The burden of cardiovascular morbidity in a European Mediterranean population with multimorbidity: a cross-sectional study.Effectiveness, safety and costs of thromboembolic prevention in patients with non-valvular atrial fibrillation: phase I ESC-FA protocol study and baseline characteristics of a cohort from a primary care electronic database.Quality Reporting of Multivariable Regression Models in Observational Studies: Review of a Representative Sample of Articles Published in Biomedical JournalsDabigatran and vitamin K antagonists' use in naïve patients with non-valvular atrial fibrillation: a cross-sectional study of primary care-based electronic health records.Drug Therapy for Rate and Rhythm Control in Nonvalvular Atrial Fibrillation: A Cross-sectional Study With Electronic Health Records in a Primary Care Cohort.24-h pulse pressure cutoff point definition by office pulse pressure in a population of Spanish older hypertensive patients.[Use of multiple regression models in observational studies (1970-2013) and requirements of the STROBE guidelines in Spanish scientific journals].Effectiveness and safety of drugs used for stroke prevention in a cohort of non-valvular atrial fibrillation patients from a primary care electronic database.Multimorbidity patterns in the elderly: a prospective cohort study with cluster analysis.Survival in relation to multimorbidity patterns in older adults in primary care in Barcelona, Spain (2010-2014): a longitudinal study based on electronic health records.Annual costs attributed to atrial fibrillation management: cross-sectional study of primary healthcare electronic records.Prevalence of undiagnosed atrial fibrillation and of that not being treated with anticoagulant drugs: the AFABE study.Comparative analysis of methods for identifying multimorbidity patterns: a study of 'real-world' data.Reply: contribution of the ABP-International study to the definition of night-time tachycardia.Multimorbidity patterns with K-means nonhierarchical cluster analysis.Patrones de multimorbilidad en adultos jóvenes en Cataluña: un análisis de clústeresDisease networks identify specific conditions and pleiotropy influencing multimorbidity in the general populationEffectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and GermanyMedication patterns in older adults with multimorbidity: a cluster analysis of primary care patients.[Effectiveness, safety and costs of stroke prevention in non-valvular auricular fibrillation. Study of cohorts matched by Propensity score]Confidence interval reporting for measures of association in multivariable regression models in observational studiesThe Immune Response in Nonmetastatic Axillary Lymph Nodes Is Associated with the Presence of Axillary Metastasis and Breast Cancer Patient OutcomePatterns of Multimorbidity in a Population-Based Cohort of Older People: Sociodemographic, Lifestyle, Clinical, and Functional DifferencesSoft clustering using real-world data for the identification of multimorbidity patterns in an elderly population: cross-sectional study in a Mediterranean populationTWELVE-YEAR CLINICAL TRAJECTORIES OF MULTIMORBIDITY IN OLDER ADULTS: A POPULATION-BASED STUDY
P50
Q30765311-E77C190C-41C5-445D-A49F-01704F5559E5Q33768268-96B88D8B-3A03-4134-803D-188360A28DA1Q33834390-38DA935E-A9C6-4738-BD3C-4D71535959C9Q35130612-574843E2-4825-461B-AEAF-94B1D060EA30Q35829286-098D41CF-4E5C-4E32-ACD2-1ABEBA6BC89EQ36181307-5B61F3DC-2CE3-4CD5-9597-2F378DA5EFF5Q36526677-D8B67EBB-852E-4020-8440-D89FD644EEB3Q36993092-9A61AC02-BC8F-4859-BC56-C5801781F961Q38671030-CE962967-856B-4AB0-894A-ED5B2A596620Q39960076-44D9283E-72E0-4DA7-B67E-CEA21DE0D634Q40366420-6182F255-F756-4C86-9430-3FD63427D4C4Q41140551-E6DF40B6-AF98-419C-ABDD-CF64C88A639CQ47626890-62DF0E75-72AF-4363-BFA7-06D4CA9855EAQ47655709-592B8652-B0D4-4177-8F36-FF351933CDAFQ47657904-215C1797-95A7-43FD-85D1-EFAC5E8A870DQ49722527-4C1B4B06-BBE3-4F37-82B5-4C66FD7AC438Q51143131-0CDA3ADB-1E82-4808-973D-8B73CBA67B4FQ52639434-50FC6356-51AF-407F-97DC-DB1FF17DFF5DQ53084636-1D60FE77-E465-4D09-AE77-EB9018F21B3BQ55605578-5E999808-7153-4D3C-9A69-873F1B8067CEQ57931379-03B96F9E-B0FC-4FE9-BC93-C171A2DE337EQ58107316-067CF1B2-633B-433C-AFAF-A725296801C8Q62023144-0E15296B-00F7-4368-A2F1-171FE7404595Q64988726-5840515D-2BE1-4F72-BD8C-8513DCE0E2D1Q90259832-47B65617-91AA-4314-A173-7717AA401AE5Q91182487-5D94F2D7-4593-41D6-8D12-4A31869F33C3Q92184781-787533C5-395E-4E51-BA4A-859D68C72C5AQ92270166-4EFDB3A3-69C3-4A92-BD81-EA6CBFB7390FQ93022388-A81A58DB-655C-4C05-B10B-0D3088B848F1Q94175019-ADF54628-FC4E-4BAE-AEB1-BB447AEAAC4A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Albert Roso-Llorach
@ast
Albert Roso-Llorach
@en
Albert Roso-Llorach
@es
Albert Roso-Llorach
@nl
Albert Roso-Llorach
@sl
type
label
Albert Roso-Llorach
@ast
Albert Roso-Llorach
@en
Albert Roso-Llorach
@es
Albert Roso-Llorach
@nl
Albert Roso-Llorach
@sl
altLabel
Albert Roso
@en
prefLabel
Albert Roso-Llorach
@ast
Albert Roso-Llorach
@en
Albert Roso-Llorach
@es
Albert Roso-Llorach
@nl
Albert Roso-Llorach
@sl
P106
P1960
lQzSn0UAAAAJ
P21
P31
P496
0000-0002-9264-0405